Wells Fargo’s UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share UPH.WS Stock Holding History

Wells Fargo’s Portfolio UPH.WS Stock Details UPH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$1	–	7780
2023 Q3	$1	Buy	+100	New	+$2	﹤0.01%	7556
2023 Q1	–	Sell	-100	Closed	-$1	–	7827
2022 Q4	$1	Buy	+100	New	+$4	﹤0.01%	7425
2022 Q1	–	Sell	-76,100	Closed	-$22K	–	8113
2021 Q4	$22K	Hold	76,100	–	–	﹤0.01%	6311
2021 Q3	$35K	Buy	76,100 +20,000	+36%	+$12.7K	﹤0.01%	5766
2021 Q2	$48K	Buy	+56,100	New	+$57.2K	﹤0.01%	5580

Other funds holding UPH.WS

Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

Wells Fargo's UPH.WS Position: Q4 2023 in Review

Wells Fargo sold out of UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) in Q4 2023, closing a stake of 100 shares — an estimated $1 sold.

Wells Fargo first reported a position in UPH.WS in Q2 2021 and held it in 5 quarters. The position peaked at $48K in Q2 2021. 1 fund tracked by Wall St. Rank holds UPH.WS as of Q4 2023.

Wells Fargo reported no remaining UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share position as of Q4 2023 after selling out during the quarter.
Wells Fargo sold 100 UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share shares in Q4 2023, an estimated $1.
Wells Fargo first reported a position in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share in Q2 2021 and held it in 5 quarters.
Wells Fargo's UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share position peaked at $48K in Q2 2021.
1 fund tracked by Wall St. Rank held UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.